EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

p53 and p21 Status Influences Cellular Response to Metformin in KRAS-Mutant HCT116 Colorectal Cancer Cells

Asma Saeed, Jamila Hijazi iD, Zainab Bashir iD, Pierre Khoueiry, Assaad A Eid, Nadine Darwiche iD, Maria Teresa Bengoechea-Alonso iD, Johan Ericsson, Borbala I Mifsud iD, Georges Nemer iD

Current Issues in Molecular Biology · 17.07.2026 · 48 (7) · 731

DOI: 10.3390/cimb48070731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 17.07.2026. Verfasst von Asma Saeed und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Health and Life Sciences, Hamad Bin Khalifa University, Doha P.O. Box 34110, Qatar. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) remains a leading cause of cancer morbidity worldwide, highlighting the need for improved therapies. Metformin, a widely used antihyperglycemic agent, has gained attention for its potential antitumor properties. In this study, we evaluated the effects of the tumor suppressor genes TP53 and CDKN1A on metformin responsiveness in a KRAS-mutant CRC in vitro model using HCT116 cells harboring a G13D mutation in KRAS. Using parental (p53+/+, p21+/+) and isogenic knockout cell lines, we assessed cell-cycle distribution and transcriptomic responses following metformin treatment. In parental wild-type cells, metformin exposure was associated with a dose- and time-dependent reduction in cell viability and an increased proportion of cells in the G0/G1 phase, with significance levels across treatment conditions ranging from p = 0.03 to p < 0.0001. Loss of p53 or p21 was associated with attenuated cellular responses to metformin, with p21-deficient cells responding primarily at higher doses and prolonged exposure (72 h). Transcriptomic profiling revealed extensive differential gene expression in parental cells (1399 DEGs), compared with more limited responses in p53−/− (270 DEGs) and p21−/− cells (32 DEGs). Differentially expressed genes associated with MAPK signaling (DUSP5) and inflammatory regulation (TNFAIP3) were observed across genotypes, whereas pathway enrichment of DNA replication and chromatin organization was specific to p53-deficient cells. These findings provide a transcriptomic and phenotypic characterization of genotype-dependent cellular responses to metformin and establish a basis for future mechanistic and functional validation studies.

Schlagwörter

Stichwörter der Autor:innen

HCT116KRAScolorectal cancermetforminp21p53transcriptomic analysistumor suppressor gene

Autor:innen und Institutionen

  • College of Health and Life Sciences, Hamad Bin Khalifa University, Doha P.O. Box 34110, Qatar.
  • Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut P.O. Box 110236, Lebanon.
  • Department of Anatomy, Cell Biology, and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut P.O. Box 110236, Lebanon.

ORCID-Profile: Jamila Hijazi, Zainab Bashir, Nadine Darwiche, Maria Teresa Bengoechea-Alonso, Borbala I Mifsud, Georges Nemer

Zitieren

APA

Saeed, A., Hijazi, J., Bashir, Z., Khoueiry, P., Eid, A. A., Darwiche, N., Bengoechea-Alonso, M. T., Ericsson, J., Mifsud, B. I., & Nemer, G. (2026). p53 and p21 Status Influences Cellular Response to Metformin in KRAS-Mutant HCT116 Colorectal Cancer Cells. Current Issues in Molecular Biology, 48(7), 731. https://doi.org/10.3390/cimb48070731

Vancouver

Saeed A, Hijazi J, Bashir Z, Khoueiry P, Eid AA, Darwiche N, et al. p53 and p21 Status Influences Cellular Response to Metformin in KRAS-Mutant HCT116 Colorectal Cancer Cells. Current Issues in Molecular Biology. 2026;48(7):731. doi:10.3390/cimb48070731

BibTeX
@article{Saeed2026,
  author = {Saeed, Asma and Hijazi, Jamila and Bashir, Zainab and Khoueiry, Pierre and Eid, Assaad A and Darwiche, Nadine and Bengoechea-Alonso, Maria Teresa and Ericsson, Johan and Mifsud, Borbala I and Nemer, Georges},
  title = {p53 and p21 Status Influences Cellular Response to Metformin in KRAS-Mutant HCT116 Colorectal Cancer Cells},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {7},
  pages = {731},
  doi = {10.3390/cimb48070731}
}
Kostenlos starten →